drugset / Trial / NCT05082688

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

NCT05082688

RandomizedParallel-groupOpen-labelBasic science

Summary

Vaccines are used to prevent infectious diseases worldwide. Unfortunately, many vaccines, like the flu vaccine, are less effective in older adults. This single-centre open label partially randomised, partially placebo-controlled trial evaluates the differences in immune response between young and older adults after vaccination with a quadrivalent inactivated influenza vaccine and an adjuvanted herpes zoster vaccination. Exploring the underlying mechanisms between the differences in immunogenicity can provide important information for future vaccine development.

Timeline

Start
2021-09-20
Primary completion
2023-05-17
Completion
2023-05-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluarix Tetra Vaccine
Subject VARICELLA ZOSTER VIRUS ENVELOPE GLYCOPROTEIN E Vaccine

Indications